معرفی
Abraham Galan Morant is a researcher affiliated with the Department of Pharmacology at the University of Valencia. He earned his Ph.D. from the same institution in 2016, focusing on the synthesis and biological evaluation of novel substituted isoquinolines.
His research interests lie at the intersection of medicinal chemistry and pharmacology, particularly in the design and development of bioactive heterocyclic compounds. His doctoral work explored dual-function molecules with potential antibacterial, antifungal, and dopaminergic activities, reflecting a multidisciplinary approach to drug discovery.
The trends in his research, as inferred from his thesis topic, suggest a strong emphasis on synthetic organic chemistry applied to therapeutic development, especially targeting infectious diseases and neurological pathways. This work aligns with broader efforts in pharmaceutical sciences to develop multifunctional agents with improved efficacy.
While no formal scientific awards or publications are listed in the provided text, his training under a supervisory team including Dr. Diego M. Cortes Martínez, Dr. María Jesús Sanz Ferrando, and Dr. Nuria Cabedo Escrig indicates integration into an established research group in pharmacological sciences.
There is no information available about students he may have supervised or grants he has led. Similarly, details about specific laboratories or collaborative teams are not mentioned in the current data.
